Olivia G. Beck & Melissa M. Hardesty. (2023). Entrectinib use in a platinum-refractory mucinous ovarian cancer harboring a NTRK3 gene fusion. Elsevier.
Chicago Style (17th ed.) CitationOlivia G. Beck and Melissa M. Hardesty. Entrectinib Use in a Platinum-refractory Mucinous Ovarian Cancer Harboring a NTRK3 Gene Fusion. Elsevier, 2023.
MLA (9th ed.) CitationOlivia G. Beck and Melissa M. Hardesty. Entrectinib Use in a Platinum-refractory Mucinous Ovarian Cancer Harboring a NTRK3 Gene Fusion. Elsevier, 2023.
Warning: These citations may not always be 100% accurate.